$GCTK
GlucoTrack Inc

2013 Q1 Form 10-K Financial Statement

#000117891313000956 Filed on April 01, 2013

View on sec.gov

Income Statement

Concept 2013 Q1 2012 2011 Q4
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $183.6K $852.9K $50.00K
YoY Change -8.21% -12.07% -61.54%
% of Gross Profit
Research & Development $504.2K $1.921M $550.0K
YoY Change 13.3% 7.34% 111.54%
% of Gross Profit
Depreciation & Amortization $7.027K $25.55K $0.00
YoY Change 8.16% 10.85% -100.0%
% of Gross Profit
Operating Expenses $687.8K $2.774M $600.0K
YoY Change 54.54% 55.01% 57.89%
Operating Profit -$687.8K -$2.774M
YoY Change 6.15% 18.86%
Interest Expense -$660.0K -$20.00K $0.00
YoY Change -6700.0% 100.0% -100.0%
% of Operating Profit
Other Income/Expense, Net $30.00K
YoY Change -250.0%
Pretax Income -$1.340M -$2.772M -$600.0K
YoY Change 112.7% 17.26% -4.76%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.344M -$2.772M -$600.0K
YoY Change 111.61% 17.26% -4.76%
Net Earnings / Revenue
Basic Earnings Per Share -$0.52
Diluted Earnings Per Share -$3.23 -$0.52 -$1.70
COMMON SHARES
Basic Shares Outstanding 5.461M 5.315M shares
Diluted Shares Outstanding 5.315M shares

Balance Sheet

Concept 2013 Q1 2012 2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.330M $540.0K $1.900M
YoY Change 275.35% -71.58% 27.52%
Cash & Equivalents $5.325M $540.0K $1.897M
Short-Term Investments
Other Short-Term Assets $72.51K $80.00K $92.82K
YoY Change 11.74% -11.11% 8.3%
Inventory
Prepaid Expenses $21.28K
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $5.398M $620.0K $1.989M
YoY Change 264.47% -68.84% 25.91%
LONG-TERM ASSETS
Property, Plant & Equipment $65.52K $70.00K $82.87K
YoY Change -18.49% -12.5% 44.5%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $120.0K $120.0K $110.0K
YoY Change -7.69% 9.09% -15.38%
Total Long-Term Assets $187.8K $190.0K $193.2K
YoY Change -9.61% 0.0% 1.31%
TOTAL ASSETS
Total Short-Term Assets $5.398M $620.0K $1.989M
Total Long-Term Assets $187.8K $190.0K $193.2K
Total Assets $5.586M $810.0K $2.182M
YoY Change 230.75% -62.84% 23.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $143.0K $120.0K $71.76K
YoY Change 40.25% 71.43% 572.82%
Accrued Expenses $300.0K $80.36K
YoY Change 42.86% -61.73%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $40.00K $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $504.6K $460.0K $283.0K
YoY Change 55.74% 64.29% -1.75%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.750M $860.0K $930.0K
YoY Change 294.74% -7.53% 5.68%
Total Long-Term Liabilities $3.754M $860.0K $930.0K
YoY Change 295.16% -7.53% 5.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $504.6K $460.0K $283.0K
Total Long-Term Liabilities $3.754M $860.0K $930.0K
Total Liabilities $4.259M $1.320M $1.214M
YoY Change 234.65% 9.09% 3.56%
SHAREHOLDERS EQUITY
Retained Earnings -$17.01M -$12.52M
YoY Change 29.31% 23.29%
Common Stock $14.71M $13.46M
YoY Change 8.51% 25.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.282M -$500.0K $968.2K
YoY Change
Total Liabilities & Shareholders Equity $5.586M $810.0K $2.182M
YoY Change 230.75% -62.84% 23.26%

Cashflow Statement

Concept 2013 Q1 2012 2011 Q4
OPERATING ACTIVITIES
Net Income -$1.344M -$2.772M -$600.0K
YoY Change 111.61% 17.26% -4.76%
Depreciation, Depletion And Amortization $7.027K $25.55K $0.00
YoY Change 8.16% 10.85% -100.0%
Cash From Operating Activities -$645.4K -$2.297M -$580.0K
YoY Change 35.64% 19.88% 31.82%
INVESTING ACTIVITIES
Capital Expenditures $786.00 $11.35K $0.00
YoY Change -52.96% -79.23%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$10.00K $30.00K
YoY Change -100.0% -200.0%
Cash From Investing Activities -$786.00 -$17.73K $30.00K
YoY Change -94.93% -55.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $5.399M $953.5K 0.000
YoY Change -59.98% -100.0%
NET CHANGE
Cash From Operating Activities -$645.4K -$2.297M -580.0K
Cash From Investing Activities -$786.00 -$17.73K 30.00K
Cash From Financing Activities $5.399M $953.5K 0.000
Net Change In Cash $4.753M -$1.361M -550.0K
YoY Change -1067.42% -419.34% -135.71%
FREE CASH FLOW
Cash From Operating Activities -$645.4K -$2.297M -$580.0K
Capital Expenditures $786.00 $11.35K $0.00
Free Cash Flow -$646.2K -$2.308M -$580.0K
YoY Change 35.33% 17.13% 31.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 cik1506983 Area Of Leased Space
AreaOfLeasedSpace
3100 sqft
CY2010 cik1506983 Average Foreign Currency Exchange Rate Translation
AverageForeignCurrencyExchangeRateTranslation
0.282
CY2011 cik1506983 Average Foreign Currency Exchange Rate Translation
AverageForeignCurrencyExchangeRateTranslation
0.262
CY2012 cik1506983 Average Foreign Currency Exchange Rate Translation
AverageForeignCurrencyExchangeRateTranslation
0.268
cik1506983 Change In Fair Value Of Warrants With Down Round Protection
ChangeInFairValueOfWarrantsWithDownRoundProtection
-35892 USD
CY2010 cik1506983 Change In Fair Value Of Warrants With Down Round Protection
ChangeInFairValueOfWarrantsWithDownRoundProtection
USD
CY2011 cik1506983 Change In Fair Value Of Warrants With Down Round Protection
ChangeInFairValueOfWarrantsWithDownRoundProtection
USD
CY2012 cik1506983 Change In Fair Value Of Warrants With Down Round Protection
ChangeInFairValueOfWarrantsWithDownRoundProtection
-35892 USD
CY2012Q4 cik1506983 Class Of Warrant Or Right Term
ClassOfWarrantOrRightTerm
P5Y
cik1506983 Cost Of Property Repairs And Maintenance Included In Research And Development
CostOfPropertyRepairsAndMaintenanceIncludedInResearchAndDevelopment
274455 USD
CY2010 cik1506983 Cost Of Property Repairs And Maintenance Included In Research And Development
CostOfPropertyRepairsAndMaintenanceIncludedInResearchAndDevelopment
33697 USD
CY2011 cik1506983 Cost Of Property Repairs And Maintenance Included In Research And Development
CostOfPropertyRepairsAndMaintenanceIncludedInResearchAndDevelopment
33856 USD
CY2012 cik1506983 Cost Of Property Repairs And Maintenance Included In Research And Development
CostOfPropertyRepairsAndMaintenanceIncludedInResearchAndDevelopment
33035 USD
cik1506983 Financing Income Expenses Net
FinancingIncomeExpensesNet
1799692 USD
CY2010 cik1506983 Financing Income Expenses Net
FinancingIncomeExpensesNet
1397807 USD
CY2011 cik1506983 Financing Income Expenses Net
FinancingIncomeExpensesNet
30893 USD
CY2012 cik1506983 Financing Income Expenses Net
FinancingIncomeExpensesNet
-1291 USD
CY2011Q4 cik1506983 Funds In Respect Of Employee Rights Upon Retirement Noncurrent
FundsInRespectOfEmployeeRightsUponRetirementNoncurrent
110310 USD
CY2012Q4 cik1506983 Funds In Respect Of Employee Rights Upon Retirement Noncurrent
FundsInRespectOfEmployeeRightsUponRetirementNoncurrent
119488 USD
cik1506983 Increase Decrease In Funds In Respect Of Employee Rights Upon Retirement
IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement
-109192 USD
CY2010 cik1506983 Increase Decrease In Funds In Respect Of Employee Rights Upon Retirement
IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement
-25387 USD
CY2011 cik1506983 Increase Decrease In Funds In Respect Of Employee Rights Upon Retirement
IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement
14436 USD
CY2012 cik1506983 Increase Decrease In Funds In Respect Of Employee Rights Upon Retirement
IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement
-6387 USD
CY2010 cik1506983 Issuance Of Common Stock For Cash In December2010 Net Of Related Expenses Value
IssuanceOfCommonStockForCashInDecember2010NetOfRelatedExpensesValue
2357032 USD
CY2009 cik1506983 Issuance Of Common Stock For Cash In January2009 Value
IssuanceOfCommonStockForCashInJanuary2009Value
303000 USD
CY2004 cik1506983 Issuance Of Common Stock For Cash March162004 Value
IssuanceOfCommonStockForCashMarch162004Value
75000 USD
CY2011 cik1506983 Issuance Of Common Stock For Cash On April292011 Net Of Related Expenses Value
IssuanceOfCommonStockForCashOnApril292011NetOfRelatedExpensesValue
191722 USD
CY2005 cik1506983 Issuance Of Common Stock For Cash On April52005 Value
IssuanceOfCommonStockForCashOnApril52005Value
500000 USD
CY2006 cik1506983 Issuance Of Common Stock For Cash On August152006 Value
IssuanceOfCommonStockForCashOnAugust152006Value
200000 USD
CY2006 cik1506983 Issuance Of Common Stock For Cash On December142006 Value
IssuanceOfCommonStockForCashOnDecember142006Value
1372495 USD
CY2012 cik1506983 Issuance Of Common Stock For Cash One Value
IssuanceOfCommonStockForCashOneValue
917179 USD
CY2005 cik1506983 Issuance Of Common Stock For Cash On January142005 Value
IssuanceOfCommonStockForCashOnJanuary142005Value
375000 USD
CY2006 cik1506983 Issuance Of Common Stock For Cash On January262006 Value
IssuanceOfCommonStockForCashOnJanuary262006Value
128205 USD
CY2011 cik1506983 Issuance Of Common Stock For Cash On January312011 Net Of Related Expenses Value
IssuanceOfCommonStockForCashOnJanuary312011NetOfRelatedExpensesValue
83180 USD
CY2011 cik1506983 Issuance Of Common Stock For Cash On July292011 Net Of Related Expenses Value
IssuanceOfCommonStockForCashOnJuly292011NetOfRelatedExpensesValue
1466385 USD
CY2006 cik1506983 Issuance Of Common Stock For Cash On June162006 Value
IssuanceOfCommonStockForCashOnJune162006Value
50000 USD
CY2006 cik1506983 Issuance Of Common Stock For Cash On June302006 Value
IssuanceOfCommonStockForCashOnJune302006Value
51180 USD
CY2006 cik1506983 Issuance Of Common Stock For Cash On March312006 Value
IssuanceOfCommonStockForCashOnMarch312006Value
6890 USD
CY2011 cik1506983 Issuance Of Common Stock For Cash On March312011 Net Of Related Expenses Value
IssuanceOfCommonStockForCashOnMarch312011NetOfRelatedExpensesValue
479901 USD
CY2005 cik1506983 Issuance Of Common Stock For Cash On May312005 Value
IssuanceOfCommonStockForCashOnMay312005Value
200000 USD
CY2011 cik1506983 Issuance Of Common Stock For Cash On May312011 Net Of Related Expenses Value
IssuanceOfCommonStockForCashOnMay312011NetOfRelatedExpensesValue
180026 USD
CY2004 cik1506983 Issuance Of Common Stock For Cash On November252004 Value
IssuanceOfCommonStockForCashOnNovember252004Value
128856 USD
CY2006 cik1506983 Issuance Of Common Stock For Cash On October52006 Value
IssuanceOfCommonStockForCashOnOctober52006Value
1300000 USD
CY2008 cik1506983 Issuance Of Common Stock For Cash On October72008 Value
IssuanceOfCommonStockForCashOnOctober72008Value
500000 USD
CY2008 cik1506983 Issuance Of Common Stock For Cash On September272008 Value
IssuanceOfCommonStockForCashOnSeptember272008Value
342000 USD
cik1506983 Issuance Of Common Stock For Cash September302001 Value
IssuanceOfCommonStockForCashSeptember302001Value
40442 USD
cik1506983 Linkage Difference On Principal Of Loans From Stockholders
LinkageDifferenceOnPrincipalOfLoansFromStockholders
186898 USD
CY2010 cik1506983 Linkage Difference On Principal Of Loans From Stockholders
LinkageDifferenceOnPrincipalOfLoansFromStockholders
15909 USD
CY2011 cik1506983 Linkage Difference On Principal Of Loans From Stockholders
LinkageDifferenceOnPrincipalOfLoansFromStockholders
24934 USD
CY2012 cik1506983 Linkage Difference On Principal Of Loans From Stockholders
LinkageDifferenceOnPrincipalOfLoansFromStockholders
9849 USD
CY2012Q4 cik1506983 Monthly Lease Commitment
MonthlyLeaseCommitment
3080 USD
CY2012Q4 cik1506983 Monthly Lease Commitment
MonthlyLeaseCommitment
11500 ILS
CY2011Q4 cik1506983 Number Of Securities Registered
NumberOfSecuritiesRegistered
1295545
CY2012Q4 cik1506983 Number Of Shares Offered
NumberOfSharesOffered
785714
CY2012 cik1506983 Percent Of Future Sales Designated To Repay Stockholders Loans
PercentOfFutureSalesDesignatedToRepayStockholdersLoans
0.1
cik1506983 Proceeds From Issuance Of Common Stock Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts
11323559 USD
CY2010 cik1506983 Proceeds From Issuance Of Common Stock Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts
2357032 USD
CY2011 cik1506983 Proceeds From Issuance Of Common Stock Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts
2401214 USD
CY2012 cik1506983 Proceeds From Issuance Of Common Stock Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts
917179 USD
cik1506983 Professional Fees Included In Research And Development
ProfessionalFeesIncludedInResearchAndDevelopment
1705505 USD
CY2010 cik1506983 Professional Fees Included In Research And Development
ProfessionalFeesIncludedInResearchAndDevelopment
94711 USD
CY2011 cik1506983 Professional Fees Included In Research And Development
ProfessionalFeesIncludedInResearchAndDevelopment
210674 USD
CY2012 cik1506983 Professional Fees Included In Research And Development
ProfessionalFeesIncludedInResearchAndDevelopment
262752 USD
CY2009 cik1506983 Repayment Of Receivable In Respect Of Stock Issuance
RepaymentOfReceivableInRespectOfStockIssuance
75000 USD
cik1506983 Salaries And Related Expenses Included In Research And Development
SalariesAndRelatedExpensesIncludedInResearchAndDevelopment
6136912 USD
CY2010 cik1506983 Salaries And Related Expenses Included In Research And Development
SalariesAndRelatedExpensesIncludedInResearchAndDevelopment
557042 USD
CY2011 cik1506983 Salaries And Related Expenses Included In Research And Development
SalariesAndRelatedExpensesIncludedInResearchAndDevelopment
1194170 USD
CY2012 cik1506983 Salaries And Related Expenses Included In Research And Development
SalariesAndRelatedExpensesIncludedInResearchAndDevelopment
1289890 USD
CY2010 cik1506983 Stockbased Interest Compensation To Convertible Notes Holders Value
StockbasedInterestCompensationToConvertibleNotesHoldersValue
1214943 USD
cik1506983 Travel Included In Research And Development
TravelIncludedInResearchAndDevelopment
348183 USD
CY2010 cik1506983 Travel Included In Research And Development
TravelIncludedInResearchAndDevelopment
58215 USD
CY2011 cik1506983 Travel Included In Research And Development
TravelIncludedInResearchAndDevelopment
119498 USD
CY2012 cik1506983 Travel Included In Research And Development
TravelIncludedInResearchAndDevelopment
4116 USD
CY2011Q4 cik1506983 Warrants With Down Round Protection
WarrantsWithDownRoundProtection
83899 USD
CY2012Q4 cik1506983 Warrants With Down Round Protection
WarrantsWithDownRoundProtection
USD
CY2012 dei Amendment Flag
AmendmentFlag
false
CY2012 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2012 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2012 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012 dei Document Period End Date
DocumentPeriodEndDate
2012-12-31
CY2012 dei Document Type
DocumentType
10-K
CY2012 dei Entity Central Index Key
EntityCentralIndexKey
0001506983
CY2013Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5460600
CY2012 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2012 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2012Q4 dei Entity Public Float
EntityPublicFloat
0 USD
CY2012 dei Entity Registrant Name
EntityRegistrantName
Integrity Applications, Inc.
CY2012 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2012 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
71763 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
122537 USD
CY2011Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
14101 USD
CY2012Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
25667 USD
CY2011Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
57662 USD
CY2012Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
96870 USD
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
80360 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
113595 USD
CY2011Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
125000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
154252 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
22634 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
8925 USD
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
13457828 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
14772371 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-83899 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
48007 USD
CY2010 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
511648
CY2011 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
582732
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600232
CY2011Q4 us-gaap Assets
Assets
2182499 USD
CY2012Q4 us-gaap Assets
Assets
814571 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
1989321 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
624883 USD
CY2009Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62032 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1494248 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1896504 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
543411 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
543411 USD
CY2010 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1432216 USD
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
402256 USD
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1353093 USD
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2005Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5295543
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5460600
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5295543
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5460600
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
5296 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
5461 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15298751 USD
CY2010 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2669427 USD
CY2011 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2403391 USD
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2758598 USD
CY2012 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> <!--StartFragment--> <div style="TEXT-INDENT: 0pt; DISPLAY: block"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 53.85pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <br /> </div> </td> <td style="WIDTH: 45pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> O.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Concentrations of credit risk</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 99pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. Cash and cash equivalents are deposited with major banks in Israel and the United States of America. Management believes that such financial institutions are financially sound and, accordingly, minimal credit risk exists with respect to these financial instruments.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 99pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company has no significant off-balance-sheet concentration of credit risk, such as foreign exchange contracts, option contracts or other foreign hedging arrangements.</div> <!--EndFragment--></div> </div>
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
694796 USD
CY2010 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
694796 USD
CY2011 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
USD
CY2012 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
USD
us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
53962 USD
CY2010 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
5947 USD
CY2011 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
5534 USD
CY2012 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
14506 USD
us-gaap Debt Instrument Convertible Interest Expense
DebtInstrumentConvertibleInterestExpense
200812 USD
CY2010 us-gaap Debt Instrument Convertible Interest Expense
DebtInstrumentConvertibleInterestExpense
200812 USD
CY2011 us-gaap Debt Instrument Convertible Interest Expense
DebtInstrumentConvertibleInterestExpense
USD
CY2012 us-gaap Debt Instrument Convertible Interest Expense
DebtInstrumentConvertibleInterestExpense
USD
CY2011 us-gaap Deferred Compensation Arrangement With Individual Exercise Price
DeferredCompensationArrangementWithIndividualExercisePrice
6.25
CY2012 us-gaap Deferred Compensation Arrangement With Individual Exercise Price
DeferredCompensationArrangementWithIndividualExercisePrice
6.25
CY2012Q1 us-gaap Deferred Compensation Arrangement With Individual Exercise Price
DeferredCompensationArrangementWithIndividualExercisePrice
6.25
CY2012Q4 us-gaap Deferred Compensation Arrangement With Individual Exercise Price
DeferredCompensationArrangementWithIndividualExercisePrice
7.0
CY2010Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
USD
CY2011Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
USD
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
USD
CY2010Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2393919 USD
CY2011Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2890426 USD
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3496123 USD
CY2010Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
36568 USD
CY2011Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
42137 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
47440 USD
CY2010Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2430487 USD
CY2011Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2932563 USD
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3543563 USD
us-gaap Depreciation
Depreciation
158033 USD
CY2010 us-gaap Depreciation
Depreciation
19153 USD
CY2011 us-gaap Depreciation
Depreciation
23045 USD
CY2012 us-gaap Depreciation
Depreciation
25546 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
251221 USD
CY2010 us-gaap Depreciation And Amortization
DepreciationAndAmortization
53219 USD
CY2011 us-gaap Depreciation And Amortization
DepreciationAndAmortization
22835 USD
CY2012 us-gaap Depreciation And Amortization
DepreciationAndAmortization
25546 USD
CY2011Q4 us-gaap Due To Officers Or Stockholders Noncurrent
DueToOfficersOrStockholdersNoncurrent
606144 USD
CY2012Q4 us-gaap Due To Officers Or Stockholders Noncurrent
DueToOfficersOrStockholdersNoncurrent
630575 USD
CY2010 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.7
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.46
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.52
CY2010 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2011 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
119946 USD
CY2010 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-68417 USD
CY2011 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-23993 USD
CY2012 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
8103 USD
us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
48007 USD
CY2010 us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
USD
CY2011 us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
USD
CY2012 us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
48007 USD
CY2011Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
130918 USD
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
184394 USD
us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
0.001
CY2004Q4 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
1.72
CY2005Q1 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
1.72
CY2005Q2 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
1.72
CY2005Q2 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
3.37
CY2006Q1 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
1.47
CY2006Q1 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
3.63
CY2006Q2 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
3.63
CY2006Q2 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
3.63
CY2006Q3 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
3.91
CY2006Q4 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
4.31
CY2006Q4 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
4.31
CY2008Q3 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
5.52
CY2008Q4 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
5.52
CY2009Q1 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
6.02
CY2010Q4 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
6.25
CY2010Q4 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
6.25
CY2010Q4 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
6.25
CY2011Q1 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
6.25
CY2011Q1 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
6.25
CY2011Q2 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
6.25
CY2011Q2 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
6.25
CY2011Q3 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
6.25
CY2004Q1 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
1.76
CY2012Q4 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
7.0
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-252044 USD
CY2010 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
51844 USD
CY2011 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4638 USD
CY2012 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-18147 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
912 USD
CY2010 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
912 USD
CY2011 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
USD
CY2012 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3014642 USD
CY2010 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
457495 USD
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
544145 USD
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
852908 USD
CY2010 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2788446 USD
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2364339 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2772307 USD
CY2010 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2010 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
278844 USD
CY2011 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
236434 USD
CY2012 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
277231 USD
CY2010 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-975956 USD
CY2011 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-827519 USD
CY2012 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-970307 USD
CY2010 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
4688 USD
CY2011 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
4885 USD
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
4553 USD
CY2010 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
425229 USD
CY2011 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
USD
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
USD
CY2010 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
5101 USD
CY2011 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
132325 USD
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
122333 USD
CY2010 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
262094 USD
CY2011 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
453875 USD
CY2012 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
566190 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
121992 USD
CY2010 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-14120 USD
CY2011 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
64697 USD
CY2012 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
48850 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
78192 USD
CY2010 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
78192 USD
CY2011 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
USD
CY2012 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
69418 USD
CY2010 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
46562 USD
CY2011 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
23968 USD
CY2012 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-14106 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
287960 USD
CY2010 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
123147 USD
CY2011 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-19681 USD
CY2012 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
80574 USD
us-gaap Increase Decrease In Postemployment Obligations
IncreaseDecreaseInPostemploymentObligations
206465 USD
CY2010 us-gaap Increase Decrease In Postemployment Obligations
IncreaseDecreaseInPostemploymentObligations
16284 USD
CY2011 us-gaap Increase Decrease In Postemployment Obligations
IncreaseDecreaseInPostemploymentObligations
1127 USD
CY2012 us-gaap Increase Decrease In Postemployment Obligations
IncreaseDecreaseInPostemploymentObligations
-17237 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
-19113 USD
CY2010 us-gaap Interest Expense Debt
InterestExpenseDebt
17987 USD
CY2011 us-gaap Interest Expense Debt
InterestExpenseDebt
10597 USD
CY2012 us-gaap Interest Expense Debt
InterestExpenseDebt
6605 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
686595 USD
CY2010 us-gaap Labor And Related Expense
LaborAndRelatedExpense
55995 USD
CY2011 us-gaap Labor And Related Expense
LaborAndRelatedExpense
162221 USD
CY2012 us-gaap Labor And Related Expense
LaborAndRelatedExpense
255839 USD
CY2011Q4 us-gaap Liabilities
Liabilities
1214260 USD
CY2012Q4 us-gaap Liabilities
Liabilities
1317640 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2182499 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
814571 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
283041 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
457953 USD
CY2012Q4 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
37427 USD
CY2012Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
42937 USD
CY2012Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
160286 ILS
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
12920 USD
CY2010 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
USD
CY2011 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
USD
CY2012 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12318035 USD
CY2010 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2897791 USD
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2382545 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
953527 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-320510 USD
CY2010 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29321 USD
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40183 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17734 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11574060 USD
CY2010 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1367837 USD
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1916113 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2296989 USD
us-gaap Net Income Loss
NetIncomeLoss
-63293 USD
us-gaap Net Income Loss
NetIncomeLoss
-15289826 USD
CY2003 us-gaap Net Income Loss
NetIncomeLoss
-350290 USD
CY2004 us-gaap Net Income Loss
NetIncomeLoss
-288233 USD
CY2005 us-gaap Net Income Loss
NetIncomeLoss
-1055594 USD
CY2006 us-gaap Net Income Loss
NetIncomeLoss
-1282842 USD
CY2007 us-gaap Net Income Loss
NetIncomeLoss
-1593205 USD
CY2008 us-gaap Net Income Loss
NetIncomeLoss
-1528981 USD
CY2009 us-gaap Net Income Loss
NetIncomeLoss
-1202296 USD
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-2788446 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-2364339 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-2772307 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-13490134 USD
CY2010 us-gaap Operating Income Loss
OperatingIncomeLoss
-1390639 USD
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-2333446 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-2773598 USD
CY2011Q4 us-gaap Other Assets Current
OtherAssetsCurrent
92817 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
81472 USD
CY2011Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
1189 USD
CY2012Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8925 USD
CY2010 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
119019 USD
CY2011 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-39052 USD
CY2012 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
13709 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5 USD
CY2003 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-15035 USD
CY2004 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-15069 USD
CY2005 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8542 USD
CY2006 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-57127 USD
CY2007 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
84528 USD
CY2008 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
110134 USD
CY2010 us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
USD
CY2011 us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
USD
CY2012 us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
USD
CY2009 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13367 USD
CY2010 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-119019 USD
CY2011 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
39052 USD
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13709 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
646195 USD
CY2010 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
19114 USD
CY2011 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
60360 USD
CY2012 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
166480 USD
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
270473 USD
CY2010 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
30155 USD
CY2011 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
40082 USD
CY2012 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
69974 USD
us-gaap Other General Expense
OtherGeneralExpense
1207395 USD
CY2010 us-gaap Other General Expense
OtherGeneralExpense
118058 USD
CY2011 us-gaap Other General Expense
OtherGeneralExpense
147908 USD
CY2012 us-gaap Other General Expense
OtherGeneralExpense
138871 USD
CY2011Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
211278 USD
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
297989 USD
us-gaap Other Operating Income
OtherOperatingIncome
912 USD
CY2010 us-gaap Other Operating Income
OtherOperatingIncome
912 USD
CY2011 us-gaap Other Operating Income
OtherOperatingIncome
USD
CY2012 us-gaap Other Operating Income
OtherOperatingIncome
USD
us-gaap Paid In Kind Interest
PaidInKindInterest
1214943 USD
CY2010 us-gaap Paid In Kind Interest
PaidInKindInterest
1214943 USD
CY2011 us-gaap Paid In Kind Interest
PaidInKindInterest
USD
CY2012 us-gaap Paid In Kind Interest
PaidInKindInterest
USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
388732 USD
CY2010 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
USD
CY2011 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
USD
CY2012 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
220120 USD
CY2010 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8725 USD
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
54619 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11347 USD
us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
14252 USD
CY2011Q4 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
241176 USD
CY2012Q4 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
229112 USD
CY2010 us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
28873 USD
CY2011 us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
42358 USD
CY2012 us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
78556 USD
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2011Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
21282 USD
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
29460 USD
CY2011Q4 us-gaap Prepaid Taxes
PrepaidTaxes
70346 USD
CY2012Q4 us-gaap Prepaid Taxes
PrepaidTaxes
52012 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1144000 USD
CY2010 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1144000 USD
CY2011 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
USD
CY2012 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
USD
CY2010 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4000000 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
5500000 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
347742 USD
CY2010 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
USD
CY2011 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
USD
CY2012 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
30130 USD
CY2010 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-75845 USD
CY2011 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-18669 USD
CY2012 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
36348 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
406995 USD
CY2010 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
USD
CY2011 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
USD
us-gaap Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross
ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
10569866 USD
CY2010 us-gaap Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross
ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
934056 USD
CY2012 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4791 USD
CY2010 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4791 USD
CY2011 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
USD
CY2012 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
USD
us-gaap Professional Fees
ProfessionalFees
1883855 USD
CY2010 us-gaap Professional Fees
ProfessionalFees
365398 USD
CY2011 us-gaap Professional Fees
ProfessionalFees
336308 USD
CY2012 us-gaap Professional Fees
ProfessionalFees
392832 USD
CY2011Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
207868 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
224452 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
82868 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
70200 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
527396 USD
CY2010 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
527396 USD
CY2011 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
USD
CY2012 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
USD
CY2011 us-gaap Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross
ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
1789301 USD
CY2012 us-gaap Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross
ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
1920690 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10476404 USD
CY2010 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
934056 USD
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1789301 USD
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1920690 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12517519 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15289826 USD
us-gaap Revenue From Grants
RevenueFromGrants
93462 USD
CY2004 us-gaap Revenue From Grants
RevenueFromGrants
93462 USD
CY2010 us-gaap Revenue From Grants
RevenueFromGrants
USD
CY2011 us-gaap Revenue From Grants
RevenueFromGrants
USD
CY2012 us-gaap Revenue From Grants
RevenueFromGrants
USD
CY2012 us-gaap Revenue Recognition Services Royalty Fees
RevenueRecognitionServicesRoyaltyFees
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> <!--StartFragment--> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 53.85pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <br /> </div> </td> <td style="WIDTH: 45pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> J.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Royalty-bearing grants</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 99pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Royalty-bearing grants from the Office of the Chief Scientist of the Ministry of Industry, Trade and Labor (the "OCS") for funding approved research and development projects are recognized at the time Integrity Israel is entitled to such grants, on the basis of the costs incurred and reduce research and development costs. The cumulative research and development grants received by Integrity Israel from inception through December 2004 amount to US$ 93,462. Integrity Israel has not received any research and development grants since December 2004.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 99pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As of December 31, 2012, 2011 and 2010, the Company has not accrued any royalties, since no revenues have been recognized in respect of the funded project.</div> <!--EndFragment--></div> </div>
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
110142
us-gaap Share Based Compensation
ShareBasedCompensation
1580425 USD
CY2010 us-gaap Share Based Compensation
ShareBasedCompensation
14575 USD
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
378072 USD
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
349522 USD
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2012Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.02
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.02
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.02
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.02
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
109197
CY2012Q4 us-gaap Share Price
SharePrice
6.25
CY2012Q1 us-gaap Share Price
SharePrice
6.25
CY2011Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
321039
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.81
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.81
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.12
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3328
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
29315
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
17500
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.08
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.08
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.08
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
428367
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
454354
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
471854
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.37
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.44
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.47
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.84
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.25
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.25
CY2012Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
321039
CY2012Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
471854
CY2011Q4 us-gaap Share Price
SharePrice
6.25
CY2012Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
37427 USD
CY2001Q3 us-gaap Stockholders Equity
StockholdersEquity
USD
CY2002Q4 us-gaap Stockholders Equity
StockholdersEquity
-22856 USD
CY2009 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12171 USD
CY2010 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14575 USD
CY2011 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
378072 USD
CY2012 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
349522 USD
CY2003Q4 us-gaap Stockholders Equity
StockholdersEquity
-388181 USD
CY2004Q4 us-gaap Stockholders Equity
StockholdersEquity
-487627 USD
CY2005Q4 us-gaap Stockholders Equity
StockholdersEquity
-270063 USD
CY2006Q4 us-gaap Stockholders Equity
StockholdersEquity
1776235 USD
CY2007Q4 us-gaap Stockholders Equity
StockholdersEquity
542217 USD
CY2008Q4 us-gaap Stockholders Equity
StockholdersEquity
49750 USD
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
-775742 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
598139 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
968239 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-503069 USD
CY2010 us-gaap Stockholders Equity Note Stock Split Conversion Ratio
StockholdersEquityNoteStockSplitConversionRatio
2.1363
us-gaap Stock Issued1
StockIssued1
83899 USD
CY2010 us-gaap Stock Issued1
StockIssued1
USD
CY2011 us-gaap Stock Issued1
StockIssued1
83899 USD
CY2012 us-gaap Stock Issued1
StockIssued1
USD
CY2010Q4 us-gaap Stock Issued During Period Shares Issued For Cash
StockIssuedDuringPeriodSharesIssuedForCash
482600
CY2010Q4 us-gaap Stock Issued During Period Shares Issued For Cash
StockIssuedDuringPeriodSharesIssuedForCash
48000
CY2011Q1 us-gaap Stock Issued During Period Shares Issued For Cash
StockIssuedDuringPeriodSharesIssuedForCash
16320
CY2011Q1 us-gaap Stock Issued During Period Shares Issued For Cash
StockIssuedDuringPeriodSharesIssuedForCash
90768
CY2011Q2 us-gaap Stock Issued During Period Shares Issued For Cash
StockIssuedDuringPeriodSharesIssuedForCash
40000
CY2011Q2 us-gaap Stock Issued During Period Shares Issued For Cash
StockIssuedDuringPeriodSharesIssuedForCash
34200
CY2011Q3 us-gaap Stock Issued During Period Shares Issued For Cash
StockIssuedDuringPeriodSharesIssuedForCash
269680
CY2012Q4 us-gaap Stock Issued During Period Shares Issued For Cash
StockIssuedDuringPeriodSharesIssuedForCash
165057
CY2011 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2010 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
694796 USD
CY2010Q4 us-gaap Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
3016250 USD
CY2010Q4 us-gaap Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
300000 USD
CY2011Q1 us-gaap Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
102000 USD
CY2011Q1 us-gaap Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
567300 USD
CY2011Q2 us-gaap Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
250000 USD
CY2011Q2 us-gaap Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
213750 USD
CY2011Q3 us-gaap Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
1685500 USD
CY2012Q4 us-gaap Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
1150000 USD
CY2005 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
189616 USD
CY2006 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
277497 USD
CY2007 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
274659 USD
CY2008 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
84380 USD
CY2010 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
USD
CY2011 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
USD
CY2012 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
35892 USD
us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
119757 USD
CY2010 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
USD
CY2011 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
USD
CY2012 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
119757 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
35892 USD
CY2012 us-gaap Use Of Estimates
UseOfEstimates
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> <!--StartFragment--> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 53.85pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <br /> </div> </td> <td style="WIDTH: 45pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> C.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Use of estimates in the preparation of financial statements</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 99pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 99pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As applicable to these consolidated financial statements, the most significant estimates and assumptions relate to stock based compensation and to the going concern assumption.</div> <!--EndFragment--></div> </div>
CY2010 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4034706
CY2011 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5091330
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5314800

Files In Submission

Name View Source Status
0001178913-13-000956-index-headers.html Edgar Link pending
0001178913-13-000956-index.html Edgar Link pending
0001178913-13-000956.txt Edgar Link pending
0001178913-13-000956-xbrl.zip Edgar Link pending
cik1506983-20121231.xml Edgar Link completed
cik1506983-20121231.xsd Edgar Link pending
cik1506983-20121231_cal.xml Edgar Link unprocessable
cik1506983-20121231_def.xml Edgar Link unprocessable
cik1506983-20121231_lab.xml Edgar Link unprocessable
cik1506983-20121231_pre.xml Edgar Link unprocessable
exhibit_31-1.htm Edgar Link pending
exhibit_31-2.htm Edgar Link pending
exhibit_32-1.htm Edgar Link pending
exhibit_32-2.htm Edgar Link pending
figure1.jpg Edgar Link pending
figure2.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
logo.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zk1312879.htm Edgar Link pending